Spinnaker Biosciences

Founded in 2009 and based in Solana Beach, California, Spinnaker Biosciences is a biotechnology company specializing in ophthalmic drug delivery technologies. The company's core mission is to innovate and improve drug delivery systems for eye-related treatments, leveraging advanced materials such as porous silicon, porous silicon oxide, and porous silicon/polymer composites. These materials are designed with unique optical, chemical, and structural features to enhance the efficacy and precision of drug delivery. Spinnaker Biosciences also explores applications in oncology and other medical fields.

Notable individuals affiliated with Spinnaker Biosciences include its founders, who have significant expertise in biotechnology and material sciences. The company has garnered attention from investors interested in cutting-edge medical technologies. Key achievements include the development of fusogenic liposome-coated nanoparticles, which have potential applications beyond ophthalmology. Overall, Spinnaker Biosciences has made a significant impact by advancing drug delivery technologies, particularly in the field of ophthalmology, contributing to more effective and targeted treatments.